Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands		3 Months Ended
		Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income (loss)		$ (10,504)	$ 28,676
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation		3,941	4,865
Amortization of intangible assets		1,136	1,944
Reduction in carrying amount of right-of-use asset		2,449	2,931
Provision for credit losses		14	75
Share-based compensation		19,767	19,919
Deferred income taxes		39	(65)
Provision for excess and obsolete inventory	[1]	(624)	13,485
Non-cash interest expense		282	266
Other		746	(144)
Changes in operating assets and liabilities:
Accounts receivable, net		(7,709)	50,459
Inventories	[1]	(8,669)	(25,431)
Prepaid expenses and other assets		3,096	(6,841)
Accounts payable		14,492	(20,097)
Accrued compensation and benefits		2,844	(19,488)
Operating lease liabilities		(2,757)	(3,297)
Deferred revenue		3,823	21,978
Other current and long-term liabilities		(3,781)	6,400
Net cash provided by operating activities		18,585	75,635
Cash flows from investing activities:
Capital expenditures		(6,916)	(4,314)
Net cash used in investing activities		(6,916)	(4,314)
Cash flows from financing activities:
Net payments on revolving facility			(25,000)
Payments on debt obligations		(2,500)	(2,500)
Payments on debt financing costs		(695)
Repurchase of common stock			(24,889)
Payments for tax withholdings, net of proceeds from issuance of common stock		(5,926)	(29,072)
Net cash used in financing activities		(9,121)	(81,461)
Foreign currency effect on cash and cash equivalents		299	(252)
Net increase (decrease) in cash and cash equivalents		2,847	(10,392)
Cash and cash equivalents at beginning of period		156,699	234,826
Cash and cash equivalents at end of period		$ 159,546	$ 224,434

[1] The prior period amounts have been reclassified to conform to the current period presentation